Australia Radiotherapy Market Report 2022 to 2030

Australia Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Australia Radiotherapy Market will reach a value of $148 Mn from $83 Mn in 2022, growing at a CAGR of 7.5% during 2022-2030. The Radiotherapy Therapeutics Market in Australia is dominated by a few domestic players such as Vision RT, Australian Radiotherapy, and GenesisCare. The radiotherapy market in Australia is segmented into different types, technologies, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Australian radiotherapy is increasing due to the rise in cancer cases in the country.

ID: IN10AUPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Australia AUTHOR: Dr. Vishwa Modhia

Buy Now

Australia Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Australia Radiotherapy Market will reach a value of $148 Mn from $83 Mn in 2022, growing at a CAGR of 7.5% during 2022-2030.

Australia is a high-income developed country in Oceania bordering the Indian Ocean and the Southern Pacific Ocean. Cancer is a major source of illness in Australia, accounting for 18% of the total illness burden and approximately 9% of health-system expenditure ascribed to individual diseases. Nearly 1 Mn people in Australia are now or have been diagnosed with cancer. In Australia, 74,200 radiation courses were administered in 2018-19.

Cancer survival varies by cancer, but overall cancer survival has grown, with 70% of all cancer patients living at least five years after diagnosis, up from 51% about 30 years ago. Personal and behavioural risk factors account for approximately half (42%) of the cancer burden (for example, smoking and overweight). Australia's government spent 10.7% of its GDP on healthcare in 2020.

Australia Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Australia provides a comparably smoother patient experience with shorter wait times. Half of the radiation patients were treated within 10 days, while the other half were treated within 27 days. 96 % of individuals who required emergency radiotherapy (1.5 % of courses) began treatment the same or the following day. Patients in the higher socioeconomic areas had the least wait times. The Radiation Oncology Health Program Subsidies Scheme gives grants to public and commercial radiation oncology providers in order to assist them in purchasing or replacing radiation therapy machines. Each linear accelerator will receive $3 Mn under the initiative. These aspects could boost Australia Radiotherapy Market.

Market restraints

Because of Australia's low population density, administering radiation poses geographical challenges. The disparities between Australia's federated states are vast. In Australia, effective tobacco control and comprehensive health care have lowered the burden of lung cancer. However, issues like as an ageing population, equal health care for rural and indigenous people, and smoking abolition remain obstacles. These factors may deter new entrants into the Australia Radiotherapy Market.

Competitive Landscape

Key Players

GenesisCare: GenesisCare is a healthcare provider that operates a network of cancer centres across Australia. The company offers a range of radiotherapy solutions, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic radiosurgery (SRS)
Australian Radiotherapy: Australian Radiotherapy is a company that specializes in the development and manufacture of radiotherapy equipment. The company offers a range of solutions, including linear accelerators, treatment planning systems, and brachytherapy systems
RANZCR: The Royal Australian and New Zealand College of Radiologists (RANZCR) is a professional organization representing radiologists and radiation oncologists in Australia and New Zealand. The organization plays an important role in promoting the use of radiotherapy in cancer treatment and developing standards for the delivery of radiotherapy services
Vision RT: Vision RT is a medical technology company that develops and provides real-time motion management solutions for radiation therapy. The company's products include the AlignRT system, which offers 3D surface imaging and tracking for accurate patient positioning
Oncology Ventures: Oncology Ventures is a biotechnology company that specializes in the development of personalized cancer therapies

Recent Notable Updates

December 2022: The Australian Government will contribute $3.93 Mn through Cancer Australia to the successful initiatives, while financial partners will pay $1.21 Mn. The Leukaemia Foundation, Lung Foundation Australia, My Room Children's Cancer Charity Limited, The Kids' Cancer Project, Australian Lions Childhood Cancer Research Foundation, and Can To Foundation are among the funding partners.

August 2022: AdvanCell, an Australian radiopharmaceutical business that has developed a platform technology for a novel cancer treatment known as Targeted Alpha Therapy, announced today the completion of a $12.3 Mn Series B fundraising round headed by Morningside. AdvanCell's capacity to generate isotopes on-demand and at scale, as well as its in-house radiopharmaceutical production experience, enables the company to take the lead in this rapidly increasing sector.

Healthcare Policies and Reimbursement Scenarios

In Australia, radiotherapy is regulated by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), which is responsible for ensuring the safe use of radiation in all areas, including medicine. The Australian Radiation Protection and Nuclear Safety Regulations 2018 prescribe the requirements for radiation protection and nuclear safety in Australia. The Code of Radiation Protection in Planned Exposure Situations (ARPANSA 2016), Radiation Protection Series C-1, reflects international best practices in radiation protection. Medicare benefits can be claimed for diagnostic imaging or radiation oncology services if your clinic is accredited to perform diagnostic imaging services and has a Location Specific Practice Number (LSPN).

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.